All Patents Lead to Ralph Baric
Moderna, NIAID, and Ralph Baric's Role in mRNA Vaccine Development
Synopsis
The timeline unfolds, interweaving collaborations between Moderna, NIAID, and Ralph Baric. The journey commences in 2015 with Baric's chimeric virus creation in tandem with Wuhan Institute of Virology, while Moderna and NIAID join forces to tackle coronaviruses. The plot thickens in 2016 with Moderna's patent filing, containing a genetic sequence found later in the SARS-CoV-2 furin cleavage site. A Material Transfer Agreement in 2019 allows the exchange of mRNA candidates, and by 2020, human trials for mRNA-1273 commence, propelled by financial success for Moderna's CEO. Questions arise about the 2016 patent's connection to SARS-CoV-2, creating a complex narrative reflecting the multifaceted origins and collaborations shaping the success of mRNA vaccines during the COVID-19 pandemic.
Unraveling the Timeline
Highlights the chronological events, collaborations, and questions surrounding the development of mRNA vaccines, specifically Moderna's mRNA-1273, with a focus on the 2016 patent and its connection to the SARS-CoV-2 furin cleavage site:
The peculiar connection between Moderna's 2016 patent and the genetic sequence found in the SARS-CoV-2 furin cleavage site raises questions about the origins and collaborations behind mRNA-1273.
The timeline suggests a complex interplay between Moderna, NIAID, and Ralph Baric, with implications for the development and success of mRNA vaccines.
The timeline highlights significant events, including the 2016 patent, Moderna's collaborations, the emergence of SARS-CoV-2, the development of mRNA-1273, and subsequent financial success. These events have generated interest and raised questions about the origins and development of the mRNA vaccines in response to the COVID-19 pandemic.
MODERNA’S CURIOUS 2016 PATENT
On February 21, 2022, Frontiers in Virology published a report titled MSH3 Homology and Potential Recombination Link to SARS-CoV-2 Furin Cleavage Site. The Furin Cleavage Site is the component of the SARS-CoV-2 spike protein that enables the virus to dock onto human lung epithelial cells, thereby initiating the viral infection and replication process. It is an important feature of SARS-CoV-2 that made it infectious to humans. Examining the genetic code of this part of the spike protein, the authors noted that part of the sequence was a perfect match to a genetic sequence patented in 2016 by Bancel S. et al. in Cambridge, Massachusetts.
SARS-CoV-2 Spike Protein and MSH3
A peculiar feature of the nucleotide sequence encoding the PRRA furin cleavage site in the SARS-CoV-2 S protein is its two consecutive CGG codons. This arginine codon is rare in coronaviruses: relative synonymous codon usage (RSCU) of CGG in pangolin CoV is 0, in bat CoV 0.08, in SARS-CoV 0.19, in MERS-CoV 0.25, and in SARS-CoV-2 0.299 (8).
A BLAST search for the 12-nucleotide insertion led us to a 100% reverse match in a proprietary sequence (SEQ ID11652, nt 2751-2733) found in the US patent 9,587,003 filed on Feb. 4, 2016.
On the question of whether this perfect match could be mere coincidence, the authors noted:
Conventional biostatistical analysis indicates that the probability of this sequence randomly being present in a 30,000-nucleotide viral genome is 3.21×10^-11 [approximately 1 in 3 trillion].
The Daily Mail reported the Frontiers in Virology report, which prompted Fox News’s Maria Bartiromo to question Moderna CEO Stéphane Bancel about his 2016 gene patent. His cool brushoff was suggestive of a man unconcerned about media queries. Why should he be? When it comes to the Bio-Pharmaceutical Complex, the US mainstream media rarely asks tough questions, and never pursues serious inquiry.
Inquisitive viewers might have wondered: Who is Stéphane Bancel, and why is a French national heading a Cambridge, Massachusetts biotech that was originally funded by a Defense Advanced Research Projects Agency (DARPA) grant?
As I recounted in Chapter I of this series, Bancel was the CEO of BioMérieux in the years 2007-11, when the French in vitro diagnostics company was in the early stages of planning and building a new BSL-4 lab at the Wuhan Institute of Virology. In 2011, Bancel left his plum position at bioMérieux to become CEO of Moderna. At the time it seemed like a Quixotic decision, because the company was just a concept, and not a going concern.
However, two years later, in 2013—the same year that Ralph Baric started collaborating with colleagues at the Wuhan Institute of Virology to perform gain-of-function work on bat coronaviruses, Moderna drew interest from DARPA, which awarded it a $25 million grant to develop messenger mRNA therapeutics.
Sometime around 2015—the same year in which Ralph Baric published his initial paper on the chimeric virus he created with his collaborators at the WIV with research funding provided by the NIAID—Moderna also began collaborating with the the NIAID to develop mRNA vaccines against SARS and MERS coronaviruses.
In the year 2016, Bancel et al. filed for their patent of the genetic sequence for part of the coronavirus spike protein furin cleavage site—the same genetic sequence that was, four years later, found in the furin cleavage site of SARS-CoV-2.
Bancel’s decision to leave bioMerieux to lead Moderna worked out well. On March 16, 2020—just five days after the WHO declared SARS-CoV-2 to be the causative agent of a worldwide pandemic, NIAID issued a press release stating it had commenced human trials of its mRNA-1273 vaccine.
mRNA-1273 was developed by NIAID scientists and their collaborators at the biotechnology company Moderna, Inc., based in Cambridge, Massachusetts. The Coalition for Epidemic Preparedness Innovations (CEPI) supported the manufacturing of the vaccine candidate for the Phase 1 clinical trial.
A conspicuous feature of the development timeline for mRNA-1273 is a MATERIAL TRANSFER AGREEMENT (see pages 105-107) from NIAID/Moderna (“Provider”) to Ralph Baric (“Research Recipient”). The Agreement specifies the transfer of “mRNA coronavirus vaccine candidates developed and jointly owned by NIAID and Moderna” to Dr. Baric “to perform challenge studies with the mRNA vaccine.”
Material Transfer Agreement
The Agreement is signed by Ralph Baric on December 12, 2019—19 days before the Wuhan Municipal Health Commission informed the WHO China Country Office of “cases of pneumonia of unknown etiology detected in Wuhan City, Hubei Province of China on December 31, 2019, and 24 days before the genome of SARS-CoV-2 was published on January 5, 2020.
Why did NIAID and Moderna believe that Dr. Baric was equipped to challenge their “mRNA coronavirus vaccine candidates”? Did they provide Dr. Baric with the coronaviruses to be used for his challenge studies, or did he already possess them in his laboratory?
This collaboration, which came about on the eve of the COVID-19 pandemic, proved to be very profitable for NIAID and Moderna. Less than a year later—with the United States government relentlessly pushing Moderna’s mRNA and Pfizer/BioNTech’s mRNA vaccines as the ONLY solution to the COVID-19 pandemic, Moderna’s CEO, Stephane Bancel became a billionaire.
A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence by Zhengli-Li Shi & Ralph S Baric Published: 09 November 2015
https://www.nature.com/articles/nm.3985/
Bancel et al. Moderna Patent bUS9587003.pdf
https://drive.google.com/file/d/1d-_PZiDCqtSP5L0wW4KAGXQDpS6SjgZL/view
MSH3 Homology and Potential Recombination Link to SARS-CoV-2 Furin Cleavage Site
https://www.frontiersin.org/articles/10.3389/fviro.2022.834808/full
Scientists claim Covid virus contains tiny chunk of DNA that 'matches sequence patented by Moderna THREE YEARS before pandemic began'
CEO OF MODERNA FUMBLES EXPLAINING WHY COVID-19 CONTAINS A GENE SEQUENCE PATENTED THREE YEARS AGO
https://www.bitchute.com/video/bX9cAYQ7iOJP/
DARPA Awards Moderna Therapeutics A Grant For Up To $25 Million To Develop Messenger RNA Therapeutics™
NIH Clinical Trial of Investigational Vaccine for COVID-19 Begins
https://www.niaid.nih.gov/news-events/nih-clinical-trial-investigational-vaccine-covid-19-begins
NIH-Moderna Confidential Agreements
https://www.documentcloud.org/documents/6935295-NIH-Moderna-
Pneumonia of unknown cause – China
https://www.who.int/emergencies/disease-outbreak-news/item/2020-DON229
COVID vaccines create 9 new billionaires with combined wealth greater than cost of vaccinating world's poorest countries
Missed a few things. Dr. Baric co-authored a paper with Dr. Chi (batwoman) in 2015. Where SARS 2 is being discussed. She presented the virus to Wuhan.
Also another point of interest, Dr. Baric was given a million dollar grant by NIH/ Fauci back in 2000 I believe may been 2001. Dr Baric came up with SARS I at the UNC, there is a lab named for him and a shot. The shots for SARS 2 were from this. I personally read on Pfizers website that they took that shot and their people "fiddled" with it, 42 days later they have something for mass manufacturing .
In the beginning when I was researching, you wouldn't believe what I found on the websites. CDC, things have disappeared, it will say page no longer exists, then direct you to the new and improved.
Then I stumbled, my mother has been in and out of the hospitals 4 or 5 times since she was fear mongered , this last time, home health has been out here, wearing masks , some of them, and I'm not quiet any more.
I am still at a loss as to why the medical community didn't bother to do the research that I did. Furthermore why in the hell are they still supporting it. .
I didn't go to the hospital, not once I'm not playing their game but if I had wanted to get in there , you bet your ass I would have.
My own heart doctor who I have vast respect for, told me last time I saw her,
This was after I stated that I didn't want to discuss shots.
She said, "no discussion, I just wish people would do what they are supposed to do, so that WE can get back to doing what we were doing."
😳😳😳😳
I did discuss it a few times with my internist. She was cool with discussing. She countered my points (this was early on, and I could be the poster child for their shots , and that's why she was concerned) ex.i asked her about the shots crossing the BBB, and she stated well COVID does too.
What I found interesting is she stated her and her husband (He is a cardiologist and actually the brother of my cardiologist ) she stated, that they had friends who had friends that knew someone who died of COVID, and that's why they had gotten it.
It was only later that I gave that statement some thought.
I have stated it before and I will state it again. I'm a nobody in the world. However I have an ability to see things, have witnessed the dumbing down of the people for about 35 years . It was only the last 15 or so, that I begin to get a sense of why this was occurring. Before covid, I had several places I liked to go online for social interaction. Now I go everywhere , but there are only so many hours in a day. I would guestimate that I have thousands of hours in looking, researching, then getting anything I found that I thought was credible. My family turned on me, and that's okay. My last act of kindness here , will be trying to get a county meeting where I will follow Dr. P McCollough and Sasha in presenting a document asking for the restricting of shots.
Still no clue how this patent might fit into a story.
https://danielcorcos.substack.com/p/bca